caplacizumab
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
68225-256 -
Package NDC
68225-256-00 -
SPL ID
3010e0cd-0aab-cea7-e063-6294a90afe58
What the source publishes
- Labeler
- Patheon Italia S.p.A.
- Active ingredients
- caplacizumab
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Administrative status
- present-in-source-snapshot
- Marketing status
- DRUG FOR FURTHER PROCESSING
- Product type
- DRUG FOR FURTHER PROCESSING
Names this record is found by
Complete source data
{
"name": "caplacizumab",
"splId": "3010e0cd-0aab-cea7-e063-6294a90afe58",
"labels": [],
"routes": [],
"labeler": "Patheon Italia S.p.A.",
"finished": false,
"packaging": [
{
"description": "126 CARTON in 1 CONTAINER (68225-256-00) / 247 VIAL in 1 CARTON / 2 mL in 1 VIAL",
"package_ndc": "68225-256-00",
"identifierStatus": "well-formed",
"marketing_start_date": "06-FEB-19"
}
],
"productId": "68225-256_3010e0cd-0aab-cea7-e063-6294a90afe58",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "68225-256",
"deaSchedule": null,
"genericName": "caplacizumab",
"productType": "DRUG FOR FURTHER PROCESSING",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CAPLACIZUMAB",
"strength": "11 mg/mL"
}
],
"applicationNumber": null,
"marketingCategory": "DRUG FOR FURTHER PROCESSING",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20190206",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "unknown",
"harmonizedIdentifiers": {},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:68225-256_3010e0cd-0aab-cea7-e063-6294a90afe58"